anti apobec3g monoclonal primary antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc anti apobec3g monoclonal primary antibody
    Comparison of <t>APOBEC3G</t> expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Anti Apobec3g Monoclonal Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti apobec3g monoclonal primary antibody/product/Cell Signaling Technology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti apobec3g monoclonal primary antibody - by Bioz Stars, 2023-03
    92/100 stars

    Images

    1) Product Images from "Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer"

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    Journal: Oncology Letters

    doi: 10.3892/ol.2020.11257

    Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.

    Techniques Used: Expressing, Western Blot

    Immunohistochemical detection of APOBEC3G expression in liver tissues.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues.

    Techniques Used: Immunohistochemical staining, Expressing

    Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.

    Techniques Used: Immunohistochemical staining, Expressing

    Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.

    Techniques Used:

    anti apobec3g monoclonal primary antibody  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc anti apobec3g monoclonal primary antibody
    Comparison of <t>APOBEC3G</t> expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Anti Apobec3g Monoclonal Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti apobec3g monoclonal primary antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti apobec3g monoclonal primary antibody - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer"

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    Journal: Oncology Letters

    doi: 10.3892/ol.2020.11257

    Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.

    Techniques Used: Expressing, Western Blot

    Immunohistochemical detection of APOBEC3G expression in liver tissues.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues.

    Techniques Used: Immunohistochemical staining, Expressing

    Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.

    Techniques Used: Immunohistochemical staining, Expressing

    Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.

    Techniques Used:

    anti apobec3g monoclonal primary antibody  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc anti apobec3g monoclonal primary antibody
    Comparison of <t>APOBEC3G</t> expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Anti Apobec3g Monoclonal Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti apobec3g monoclonal primary antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti apobec3g monoclonal primary antibody - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer"

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    Journal: Oncology Letters

    doi: 10.3892/ol.2020.11257

    Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.

    Techniques Used: Expressing, Western Blot

    Immunohistochemical detection of APOBEC3G expression in liver tissues.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues.

    Techniques Used: Immunohistochemical staining, Expressing

    Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.

    Techniques Used: Immunohistochemical staining, Expressing

    Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.

    Techniques Used:

    anti apobec3g monoclonal primary antibody  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc anti apobec3g monoclonal primary antibody
    Comparison of <t>APOBEC3G</t> expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Anti Apobec3g Monoclonal Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti apobec3g monoclonal primary antibody/product/Cell Signaling Technology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti apobec3g monoclonal primary antibody - by Bioz Stars, 2023-03
    92/100 stars

    Images

    1) Product Images from "Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer"

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    Journal: Oncology Letters

    doi: 10.3892/ol.2020.11257

    Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.

    Techniques Used: Expressing, Western Blot

    Immunohistochemical detection of APOBEC3G expression in liver tissues.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues.

    Techniques Used: Immunohistochemical staining, Expressing

    Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.
    Figure Legend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.

    Techniques Used: Immunohistochemical staining, Expressing

    Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.
    Figure Legend Snippet: Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.

    Techniques Used:

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • anti apobec3g monoclonal primary antibody  (Cell Signaling Technology Inc)
    92
    Cell Signaling Technology Inc anti apobec3g monoclonal primary antibody
    Comparison of <t>APOBEC3G</t> expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.
    Anti Apobec3g Monoclonal Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti apobec3g monoclonal primary antibody/product/Cell Signaling Technology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti apobec3g monoclonal primary antibody - by Bioz Stars, 2023-03
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.

    Journal: Oncology Letters

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    doi: 10.3892/ol.2020.11257

    Figure Lengend Snippet: Comparison of APOBEC3G expression in liver tissues in patients with chronic hepatitis B, liver cirrhosis or liver cancer. (A) Detection of APOBEC3G expression in liver tissues via western blotting. (B) APOBEC3G protein expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer. (C) APOBEC3G mRNA expression in patients with chronic hepatitis B, liver cirrhosis and liver cancer (*P<0.05, &P<0.01). mRNA, messenger ribonucleic acid.

    Article Snippet: Anti-APOBEC3G monoclonal primary antibody (Cell Signaling Technology) was used in this study, and β-actin was the internal control.

    Techniques: Expressing, Western Blot

    Immunohistochemical detection of APOBEC3G expression in liver tissues.

    Journal: Oncology Letters

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    doi: 10.3892/ol.2020.11257

    Figure Lengend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues.

    Article Snippet: Anti-APOBEC3G monoclonal primary antibody (Cell Signaling Technology) was used in this study, and β-actin was the internal control.

    Techniques: Immunohistochemical staining, Expressing

    Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.

    Journal: Oncology Letters

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    doi: 10.3892/ol.2020.11257

    Figure Lengend Snippet: Immunohistochemical detection of APOBEC3G expression in liver tissues. (A) hepatitis, (B) liver cirrhosis, (C) liver cancer.

    Article Snippet: Anti-APOBEC3G monoclonal primary antibody (Cell Signaling Technology) was used in this study, and β-actin was the internal control.

    Techniques: Immunohistochemical staining, Expressing

    Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.

    Journal: Oncology Letters

    Article Title: Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer

    doi: 10.3892/ol.2020.11257

    Figure Lengend Snippet: Correlation between APOBEC3G and ALT in patients with chronic hepatitis B. (A) Correlation between APOBEC3G mRNA and ALT in liver tissues. (B) Correlation between APOBEC3G protein and ALT in liver tissues. ALT, alanine aminotransferase; mRNA, messenger ribonucleic acid.

    Article Snippet: Anti-APOBEC3G monoclonal primary antibody (Cell Signaling Technology) was used in this study, and β-actin was the internal control.

    Techniques: